Investor Bill Nygren just bought this pharma giant, names two AI-adjacent stocks he likes going into 2025

Investors should consider scooping up shares of this pharmaceutical giant trading at a discount, according to longtime value investor Bill Nygren.

from International: Top News And Analysis https://ift.tt/DiGCkyc